Hyliion (NYSE:HYLN) Stock Rating Upgraded by Wall Street Zen

Key Points

• Hyliion has been upgraded from a "sell" to a "hold" rating by Wall Street Zen, reflecting a change in analyst sentiment towards the stock.
• The stock opened at $1.65 recently, with a market capitalization of $288.45 million and a one-year price range between $1.11 and $4.10.
• Insider trading activity shows that CFO Jon Panzer purchased 40,000 shares at an average price of $1.14, increasing his ownership by 4.52%.

Wall Street Zen upgraded shares of Hyliion (NYSE:HYLN - Free Report) from a sell rating to a hold rating in a research note published on Saturday.

Hyliion Stock Down 2.5%

Shares of Hyliion stock traded down $0.04 during trading on Friday, reaching $1.53. The company's stock had a trading volume of 979,049 shares, compared to its average volume of 1,355,359. Hyliion has a 52-week low of $1.11 and a 52-week high of $4.0950. The company has a market cap of $267.47 million, a price-to-earnings ratio of -4.14 and a beta of 2.73. The firm's 50-day moving average is $1.51 and its two-hundred day moving average is $1.56.

Insiders Place Their Bets

In other news, CFO Jon Panzer purchased 40,000 shares of the company's stock in a transaction on Friday, May 23rd. The stock was acquired at an average price of $1.14 per share, with a total value of $45,600.00. Following the transaction, the chief financial officer directly owned 925,669 shares of the company's stock, valued at approximately $1,055,262.66. This represents a 4.52% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Over the last three months, insiders have acquired 65,000 shares of company stock worth $73,850. Corporate insiders own 20.90% of the company's stock.

Institutional Investors Weigh In On Hyliion

Institutional investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. lifted its position in shares of Hyliion by 10.9% in the 2nd quarter. JPMorgan Chase & Co. now owns 76,835 shares of the company's stock worth $101,000 after purchasing an additional 7,574 shares during the period. AQR Capital Management LLC lifted its position in shares of Hyliion by 15.1% in the 1st quarter. AQR Capital Management LLC now owns 76,957 shares of the company's stock worth $108,000 after purchasing an additional 10,076 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Hyliion by 11.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 121,536 shares of the company's stock worth $318,000 after purchasing an additional 12,007 shares during the period. ProShare Advisors LLC lifted its position in shares of Hyliion by 47.5% in the 4th quarter. ProShare Advisors LLC now owns 39,287 shares of the company's stock worth $103,000 after purchasing an additional 12,657 shares during the period. Finally, Aquatic Capital Management LLC bought a new position in shares of Hyliion in the 4th quarter worth about $42,000. Hedge funds and other institutional investors own 22.81% of the company's stock.

Hyliion Company Profile